Effects of minocycline add-on treatment on brain morphometry and cerebral perfusion in recent-onset schizophrenia
Cristiano Chaves(Queen's University), Jorge Hallak(Centre for Addiction and Mental Health), David Araújo(Montreal Neurological Institute and Hospital), Francisco Silveira Guimarães(Universidade de São Paulo), Lauro Wichert‐Ana(Center for Translational Molecular Medicine), Antônio Waldo Zuardi(Universidade de São Paulo), Thiago Borduqui Ferrari(Center for Neurosciences), Hélio Elkis(Centre for Addiction and Mental Health), Glen B. Baker(University of Alberta), Rodrigo A. Bressan(Centre for Addiction and Mental Health), João Paulo Maia‐de‐Oliveira(Universidade Federal do Rio Grande do Norte), Serdar Dursun(Centre for Addiction and Mental Health), Antônio Carlos dos Santos(Universidade de São Paulo), João P. Machado‐de‐Sousa(Universidade de São Paulo), José A. Crippa(National Council for Scientific and Technological Development), Cristiane Reberte de Marque(Universidade de Ribeirão Preto)
Cited by 41
Related Papers
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
|American Journal of Psychiatry|2016|1.1k
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
|Psychological Medicine|2018|819
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
|Neuropsychopharmacology|2011|763
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
|Journal of Psychopharmacology|2010|530
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
|Brazilian Journal of Psychiatry|2015|484